Navigation Links
Chest journal news briefs, May 2011 issue
Date:5/2/2011

ULTRASONOGRAPHY COULD REPLACE CHEST X-RAY FOR DETERMINING SOURCE OF ACUTE SHORTNESS OF BREATH

A new study suggests that ultrasonography could replace standard chest x-ray as the first choice of technique for imaging when rapid, accurate identification of the source of acute dyspnea is needed. Italian researchers studied 404 patients admitted to the emergency department and found strong agreement between the results of chest ultrasonography and x-ray for diagnosing the underlying pulmonary disease. Chest CT, long considered the gold standard for most pulmonary diseases, was used to determine accuracy when the results of the other modalities disagreed. Ultrasonography found reliable, faster results with fewer delays and less patient exposure to radiation. Considering these findings, ultrasonography could become the routine imaging modality for patients admitted to the emergency department with dyspnea. This article is published in the May issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011;139(5):1140-1147.

RACE AND ETHNICITY CAN INFLUENCE END-OF-LIFE CARE IN THE ICU

A recent study shows a disparity in treatment choices for end-of-life care made by families for patients in the ICU based on race, ethnicity, and levels of understanding. Researchers from the University of California, San Francisco and the University of Washington compared race, ethnicity, and socioeconomic status of 3,138 patients who died in the ICU or within 30 hours of transfer from the ICU. Results showed that a number of ethnic and racial differences exist in end-of-life care in the ICU, such as those related to advance directives and family-clinician communication; however, socioeconomic status was not a consistent predictor of end-of-life care. Eliminating these disparities requires a more complete understanding of the specific cultural differences and a need to develop interventions to address them. This article is published in the May issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011;139(5):1025-1033.

CHILDHOOD OBSTRUCTIVE SLEEP APNEA SYNDROME IMPROVED BY ADENOTONSILLECTOMY

A new study analyzed changes in heart rates in children with obstructive sleep apnea syndrome (OSAS) after having adenotonsillectomy (AT) and found evidence of improvement in OSAS. Researchers from Montefiore Children's Hospital in New York studied 18 children with OSAS, a syndrome characterized by recurrent airway obstruction during sleep. OSAS disrupts normal breathing and sleep patterns and is linked to neurocognitive deficits and cardiovascular morbidities, with increased heart rate as a causative link. Age-, sex-, and BMI-matched children with primary snoring were compared with children with OSAS. Tests such as overnight polysomnography and electrocardiography were performed before and after AT. After AT, heart rate decreased and sleep-disordered breathing improved. This article is published in the May issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011;139(5):1050-1059.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. Newsbriefs from the April issue of the journal Chest
2. Rochester technology to enhance eyesight approved by FDA
3. Journal Chest: News briefs from the March 2011 issue
4. Mayo researchers, Rochester educators, students to present at science conference
5. New gift from Mother Nature’s medicine chest may help prevent and treat bone diseases
6. News briefs from the January issue of Chest
7. Bacterial life on and in humans orchestrates health and disease
8. Mother Nature and bioterrorists: Rochester battles both with $11.9 million award
9. Helical CT scans reduce lung cancer mortality by 20% compared to chest X-rays
10. Manchester team wins $1.9 million grant for cell control study
11. Chest news briefs: CPAP may cause facial changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , ... February 08, 2016 , ... ... only four states in the U.S. require dental technicians to be certified or ... the dental industry, NADL created the “What’s In Your Mouth?” campaign to inform ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women's Excellence staff, in all four locations, wore ... Wear Red Day is the first Friday each February and a day to bring ... in 3 deaths among women each year – more than all cancers combined. Go ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... Plastics, has added Kybella® to his medical and surgical expertise. Technically known as ... FDA injectable medication used as a non-surgical alternative for reduction of fat below ...
(Date:2/6/2016)... San Rafael, CA (PRWEB) , ... February 06, 2016 , ... ... 2016 Youth Ultimate Coaching Conference (YUCC) . This event brings together top non-profit leaders, ... is “Gender Equity and Girls Ultimate”. Valerio Iani, Bay Area Disc Program Director of ...
(Date:2/6/2016)... ... 06, 2016 , ... Shark Finds and Kevin Harrington, along with ... DRTV campaign with Belly Bands. , Having a dog is great—except when it wets ... and find nothing works, get Belly Bands, the easiest way to stop dogs ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016 ... of the "Label-Free Detection Market by ... 2020" report to their offering. ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ...
(Date:2/8/2016)... , Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced that it will ... ended December 31, 2015 after market close on February 9, ... conference call to discuss these financial results.    ... --> About Unilife Corporation ...
(Date:2/8/2016)... Calif. , Feb. 8, 2016  Sangamo ... in therapeutic genome editing, announced that the U.S. ... Company,s Investigational New Drug (IND) application for SB-318, ... life-long therapy for Mucopolysaccharidosis Type I (MPS I). ... enables Sangamo to initiate a Phase 1/2 clinical ...
Breaking Medicine Technology: